Keywords: Neuroinflammation, Radiotherapy, Cerebrovascular inflammation, VCAM-1, MPIOs, BBB permeability, DCE-MRI, PET, TSPO, molecular imaging, stereotactic radiosurgery, biomarkers
Motivation: Despite the advances in radiotherapy of brain tumors adverse radiation effects in healthy brain tissue can occur. Their underlying mechanisms are not fully understood, though previous research proposes the contribution of cerebrovascular impairment and neuroinflammation.
Goal(s): Evaluate the development of BBB impairment, cerebrovascular inflammation and neuroinflammation in the rat model of stereotactic radiosurgery.
Approach: Multi-modality molecular imaging including DCE-MRI, T2*-weighted MRI with VCAM-1 MPIOs and PET with TSPO-specific radiotracer.
Results: In the rat model of SRS increased BBB permeability, cerebrovascular inflammation and neuroinflammation can be detected as early as 6 weeks after irradiation and these changes evolve over time in dose-dependent manner.
Impact: It is the first study to demonstrate by in vivo imaging the progression of neuroinflammatory and cerebrovascular alterations in the rat model of SRS which helps to understand the time and dose-dependent manner of development of adverse radiation effects.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords